Back to Search
RODOLFO CURIEL, MD
MD
Rheumatology Physician
NPI: 1982663878IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
MD31952(DC)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 1982
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy.
PMID 36657109·Arthritis Rheumatol·2023
8-other
Successful treatment of refractory anti-signal recognition particle myopathy using abatacept.
PMID 23920268·Rheumatology (Oxford)·2014
5-case
Subcutaneous abatacept for the treatment of rheumatoid arthritis.
PMID 23463804·Rheumatology (Oxford)·2013
6-review
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
PMID 23124935·Arthritis Rheum·2013
2-rct
The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis.
PMID 22736096·Ann Rheum Dis·2013
4-observational
Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.
PMID 22244459·J Pediatr·2012
5-case
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis.
PMID 20597110·Arthritis Care Res (Hoboken)·2010
3-trial
The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositis.
PMID 20583105·Arthritis Care Res (Hoboken)·2010
4-observational
Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.
PMID 19853831·Best Pract Res Clin Rheumatol·2009
6-review
Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood.
PMID 18586175·Lancet·2008
6-review
International consensus on preliminary definitions of improvement in adult and juvenile myositis.
PMID 15248228·Arthritis Rheum·2004
6-review
Magnetic resonance imaging of the idiopathic inflammatory myopathies: structural and clinical aspects.
PMID 19250233·Ann N Y Acad Sci·2009
6-review
Von Willebrand factor, red cell fragmentation, and disease activity in systemic lupus erythematosus.
PMID 18815861·HSS J·2008
8-other
Phase I study combining treatment with temsirolimus and sunitinib malate in patients with advanced renal cell carcinoma.
PMID 19213664·Clin Genitourin Cancer·2009
5-case
The number needed to treat in cardiovascular clinical trials.
PMID 16616963·Int J Cardiol·2007
8-other
A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
PMID 17409822·J Thorac Oncol·2006
3-trial
The antineoplastic agent bryostatin-1 differentially regulates IFN-gamma receptor subunits in monocytic cells: transcriptional and posttranscriptional control of IFN-gamma R2.
PMID 16888033·J Immunol·2006
4-observational
Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
PMID 16849761·J Clin Oncol·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2150 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037 - Phone
- (202) 741-2222
Quick Facts
- NPI
- 1982663878
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 44
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile